Results 21 to 30 of about 165 (116)

Когда мы болеем, природа отдыхает

Corpus Mundi, 2020
Рецензия на книгу McCarthy, M., Mynott, J., & Marren P. (2020). The Consolation of Nature. Spring in the Time of Coronavirus. London: Hodder Studio.
Rastyam T. Aliev
doaj   +1 more source

EXPERIENCE IN ORGANIZING CARE FOR PATIENTS WITH CORONAVIRUS INFECTION IN A REDESIGNED INFECTIOUS DISEASES HOSPITAL

Медицина в Кузбассе, 2021
The experience of solving the problems of the functioning of engineering systems at the stages of launching and direct operation of a redesigned covid hospital is presented.
Михаил Исаакович Ликстанов, Марина Владимировна Косинова, Вадим Раисович Гатин, Вадим Гельевич Мозес, Кира Борисовна Мозес, Елена Владимировна Рудаева, Светлана Ивановна Елгина, Наталья Степановна Черных   +7 more
doaj  

Socio-economic burden of COVID-19 in the Russian Federation

Качественная клиническая практика, 2020
Purpose. Assessment of the socio-economic burden of COVID-19 in the Russian Federation (RF). Materials and methods. Identification and assessment of direct medical, direct non-medical costs, as well as indirect costs associated with the development of ...
A. S. Kolbin, D. Yu. Belousov, Yu. M. Gomon, Yu. E. Balykina, I. G. Ivanov   +4 more
doaj   +1 more source

Possibility for the use of bromhexine to prevent infection with SARS-CoV-2

Качественная клиническая практика, 2020
The routine use of bromhexine to prevent infection SARS-CoV-2 is not recommended. The use of bromhexine is possible in clinical trials.
K. A. Zagorodnikova, K. B. Mirzaev, D. A. Sychev   +2 more
doaj   +1 more source

FORMATION OF PSYCHOLOGICAL STRESS IN DOCTORS AND NURSES IN THE CONDITIONS OF THE EPIDEMIOLOGICAL HAZARD OF THE PANDEMIC COVID-19

Актуальные проблемы теоретической и клинической медицины, 2022
The article is an overview of the summary data on the formation and impact of social and psychological stress on healthcare workers during the COVID-19 pandemic.
T. I. Slazhneva, D. O. Nurmukanova
doaj   +1 more source

Can inhalations of hyaluronidase be used in acute respiratory distress-syndrome in patients with COVID-19?

Качественная клиническая практика, 2020
Hyaluronidase is currently not included into Russian or foreign guidelines on the treatment of acute respiratory distress-syndrome in patients with COVID-19, and such treatment is not supported by evidence of clinical effectiveness.
Yu. Yu. Kiselev, K. B. Mirzaev, D. A. Sychev   +2 more
doaj   +1 more source

Coronaviruses in rodents and insectivores in Altai Republic

Acta Biomedica Scientifica
Coronaviruses (family Coronaviridae, genera Alphacoronavirus, Betacoronavirus) are dangerous viral pathogens that have caused three outbreaks of severe respiratory diseases, SARS, MERS, COVID-19. In Russia, data on coronaviruses in natural reservoirs are
L. N. Yashina, S. A. Abramov, N. A. Smetannikova, B. S. Malyshev, A. V. Krivopalov, T. A. Dupal   +5 more
doaj   +1 more source

Use of etiotropic and pathogenetic medicines for COVID-19 in patients with renal failure and/or on dialysis

Качественная клиническая практика, 2020
Impaired kidney function may influence pharmacokinetics of most of the drugs, including the ones used in COVID-19. In this publication, the most important pharmacokinetic parameters and dose adjustment approaches are provided, based on The Renal Drug ...
V. M. Tsvetov, I. N. Sychev, D. A. Sychev   +2 more
doaj   +1 more source

What are the indications for combined use of hydroxychloroquine and lopinavir/ritonavir, and how should treatment safety monitoring be performed?

Качественная клиническая практика, 2020
Some guidelines describe combined use of hydroxychloroquine and lopinavir/ritonavir as one of the treatment alternatives for severe COVID-19, yet this treatment is not preferable.
Yu. Yu. Kiselev, V. M. Tsvetov, K. B. Mirzaev, D. A. Sychev   +3 more
doaj   +1 more source

Possibility to use barycytinib in patients with COVID-19, including for treatment of «cytokine storm»

Качественная клиническая практика, 2020
Until clinical trials of efficacy and safety are obtained, routine use of barycytinib in patients with COVID-19 cannot be recommended.
V. A. Otdelenov, V. M. Tsvetov, D. A. Sychev   +2 more
doaj   +1 more source